Research ArticleOpen AccessGoogle Scholar indexed
Breast Cancer Cutaneous Metastasis after Scalp Cooling for Alopecia Prevention
Oncology Center, Beneficencia Portuguesa de Sao Paulo, Sao Paulo, Brazil
Department of Dermatology, Federal University of Sao Paulo, Sao Paulo, Brazil
Oncology Center, Beneficencia Portuguesa de Sao Paulo, Sao Paulo, Brazil
Oncology Center, Beneficencia Portuguesa de Sao Paulo, Sao Paulo, Brazil
Oncology Center, Beneficencia Portuguesa de Sao Paulo, Sao Paulo, Brazil
Laboratorio Bacchi, Botucatu, Brazil
Oncology Center, Beneficencia Portuguesa de Sao Paulo, Sao Paulo, Brazil
Oncology Center, Beneficencia Portuguesa de Sao Paulo, Sao Paulo, Brazil
- 1 Oncology Center, Beneficencia Portuguesa de Sao Paulo, Sao Paulo, Brazil
- 2 Department of Dermatology, Federal University of Sao Paulo, Sao Paulo, Brazil
- 3 Oncology Center, Beneficencia Portuguesa de Sao Paulo, Sao Paulo, Brazil
- 4 Oncology Center, Beneficencia Portuguesa de Sao Paulo, Sao Paulo, Brazil
- 5 Oncology Center, Beneficencia Portuguesa de Sao Paulo, Sao Paulo, Brazil
- 6 Laboratorio Bacchi, Botucatu, Brazil
- 7 Oncology Center, Beneficencia Portuguesa de Sao Paulo, Sao Paulo, Brazil
- 8 Oncology Center, Beneficencia Portuguesa de Sao Paulo, Sao Paulo, Brazil
Journal of Cancer Therapy·Volume 11 (2020)·Pages 745–748·Published 4 November 2020·DOI10.4236/jct.2020.1111064
Copy link · social · email
Abstract
Scalp cooling is a widely used method to prevent chemotherapy-induced transient alopecia. Although the success rates in maintaining hair can be high, authors have expressed their concerns regarding the risk of scalp metastasis after scalp cooling. We report a case of breast cancer scalp metastasis in a patient submitted to scalp cooling for alopecia prevention and discuss the physiopathology, risks and benefits of this treatment for patients under this treatment.
KeywordsSkin MetastasisScalp CoolingChemotherapy-Induced Alopecia
- Trüeb, R.M. (2009) Chemotherapy-Induced Alopecia. Seminars in Cutaneous Medicine and Surgery, 28, 11-14. https://doi.org/10.1016/j.sder.2008.12.001
- Lemieux, J., Desbiens, C. and Hogue, J.C. (2011) Breast Cancer Scalp Metastasis as First Metastatic Site after Scalp Cooling: Two Cases of Occurrence after 7- and 9-Year Follow-Up. Breast Cancer Research and Treatment, 128, 563-566. https://doi.org/10.1007/s10549-011-1453-y
- Rodríguez-Martín, A.M., Ruano-Ruiz, J. and Vélez-García-Nieto, A. (2016) Cutaneous Metastases: Clinical and Dermatoscopically Simulating Multiple Dermatofibromas. International Journal of Dermatology, 55, 574-576. https://doi.org/10.1111/ijd.12895
- Alcaraz, I., Cerroni, L., Rütten, A., et al. (2012) Cutaneous Metastases from Internal Malignancies: A Clinicopathologic and Immunohistochemical Review. The American Journal of Dermatopathology, 34, 347-393. https://doi.org/10.1097/DAD.0b013e31823069cf
- Nangia, J., Wang, T., Osborne, C., Nivarath, P., Otte, K., Papish, S., et al. (2017) Effect of a Scalp Cooling Device on Alopecia in Women Undergoing Chemotherapy for Breast Cancer: The SCALP Randomized Clinical Trial. JAMA, 317, 596-605. https://doi.org/10.1001/jama.2016.20939
- Shah, V.V., Wikramanayake, T.C., DelCanto, G.M., van der Hurk, C., Wu, S., Lacouture, M., et al. (2018) Scalp Hypothermia as a Preventative Measure for Chemotherapy-Induced Alopecia: A Review of Controlled Clinical Trials. Journal of the European Academy of Dermatology and Venereology, 32, 720-734. https://doi.org/10.1111/jdv.14612
- Rugo, H.S., Melin, S.A. and Voigt, J. (2017) Scalp Cooling with Adjuvant/Neoadjuvant Chemotherapy for Breast Cancer and the Risk of Scalp Metastases: Systematic Review and Meta-Analysis. Breast Cancer Research and Treatment, 163, 199-205. https://doi.org/10.1007/s10549-017-4185-9
- Krathen, R.A., Orengo, I.F. and Rosen, T. (2003) Cutaneous Metastasis: A Meta-Analysis of Data. Southern Medical Journal, 96, 164-167.
- van den Hurk, C.J., van de Poll-Franse, L.V., Breed, W.P., Corbergh, J.W.W. and Nortier, J.W.R. (2013) Scalp Cooling to Prevent Alopecia after Chemotherapy Can Be Considered Safe in Patients with Breast Cancer. Breast, 22, 1001-1004. https://doi.org/10.1016/j.breast.2013.07.039